Literature DB >> 30030635

Predictors of survival in spinocerebellar ataxia type 2 population from Southern Italy.

Antonella Antenora1, Dario Bruzzese2, Maria Lieto1, Alessandro Roca1, Maria Teresa Florio1, Silvio Peluso1, Francesco Saccà1, Giuseppe De Michele1, Filippo Maria Santorelli3, Alessandro Filla4.   

Abstract

One hundred-eighteen spinocerebellar ataxia type 2 patients from 35 distinct families personally observed between 1973 and 2016 were retrospectively reviewed. The time point of data collection was 1 January 2017. Thirty-one patients were confined to wheelchair. The median time to wheelchair was 21 years (95% CI, 17.5-24.6). Thirty-seven patients were deceased. The median time to death was 25 years (95% CI, 22.9-27.1). CAG repeat number and ataxia score at first visit influenced the time to wheelchair and death.

Entities:  

Keywords:  Ataxia scale; CAG repeats; SCA2; Survival

Mesh：

Substances：

Year:  2018        PMID： 30030635     DOI： 10.1007/s10072-018-3504-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  8 in total

Review 1.  The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.

Authors:  Luis Ruano; Claudia Melo; M Carolina Silva; Paula Coutinho
Journal:  Neuroepidemiology       Date:  2014-03-05       Impact factor: 3.282

2.  The natural history of degenerative ataxia: a retrospective study in 466 patients.

Authors:  T Klockgether; R Lüdtke; B Kramer; M Abele; K Bürk; L Schöls; O Riess; F Laccone; S Boesch; I Lopes-Cendes; A Brice; R Inzelberg; N Zilber; J Dichgans
Journal:  Brain       Date:  1998-04       Impact factor: 13.501

3.  Genetic data and natural history of Friedreich's disease: a study of 80 Italian patients.

Authors:  A Filla; G DeMichele; G Caruso; R Marconi; G Campanella
Journal:  J Neurol       Date:  1990-10       Impact factor: 4.849

4.  Autosomal dominant cerebellar ataxias in Spain: molecular and clinical correlations, prevalence estimation and survival analysis.

Authors:  J Infante; O Combarros; V Volpini; J Corral; J Llorca; J Berciano
Journal:  Acta Neurol Scand       Date:  2005-06       Impact factor: 3.209

5.  Estimation of survival in spinocerebellar ataxia type 2 Cuban patients.

Authors:  L E Almaguer-Mederos; R Aguilera Rodríguez; Y González Zaldivar; D Almaguer Gotay; D Cuello Almarales; J Laffita Mesa; Y Vázquez Mojena; P Zayas Feria; G Auburger; S Gispert; L Velásquez Pérez
Journal:  Clin Genet       Date:  2012-07-03       Impact factor: 4.438

6.  Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.

Authors:  Alhassane Diallo; Heike Jacobi; Arron Cook; Robyn Labrum; Alexandra Durr; Alexis Brice; Perrine Charles; Cecilia Marelli; Caterina Mariotti; Lorenzo Nanetti; Marta Panzeri; Maria Rakowicz; Anna Sobanska; Anna Sulek; Tanja Schmitz-Hübsch; Ludger Schöls; Holger Hengel; Bela Melegh; Alessandro Filla; Antonella Antenora; Jon Infante; José Berciano; Bart P van de Warrenburg; Dagmar Timmann; Sylvia Boesch; Massimo Pandolfo; Jörg B Schulz; Peter Bauer; Paola Giunti; Jun-Suk Kang; Thomas Klockgether; Sophie Tezenas du Montcel
Journal:  Lancet Neurol       Date:  2018-03-13       Impact factor: 44.182

7.  Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.

Authors:  Alfredo Brusco; Cinzia Gellera; Claudia Cagnoli; Alessandro Saluto; Alessia Castucci; Chiara Michielotto; Vincenza Fetoni; Caterina Mariotti; Nicola Migone; Stefano Di Donato; Franco Taroni
Journal:  Arch Neurol       Date:  2004-05

Review 8.  The Multiple Faces of Spinocerebellar Ataxia type 2.

Authors:  Antonella Antenora; Carlo Rinaldi; Alessandro Roca; Chiara Pane; Maria Lieto; Francesco Saccà; Silvio Peluso; Giuseppe De Michele; Alessandro Filla
Journal:  Ann Clin Transl Neurol       Date:  2017-08-10       Impact factor: 4.511
  8 in total
  1 in total

1.  Hereditary Ataxias in Cuba: A Nationwide Epidemiological and Clinical Study in 1001 Patients.

Authors:  Luis Velázquez-Pérez; Jacqueline Medrano-Montero; Roberto Rodríguez-Labrada; Nalia Canales-Ochoa; Jandy Campins Alí; Frank J Carrillo Rodes; Tania Rodríguez Graña; María O Hernández Oliver; Raul Aguilera Rodríguez; Yennis Domínguez Barrios; Reydenis Torres Vega; Lissi Flores Angulo; Noharis Y Cordero Navarro; Aldo A Sigler Villanueva; Osiel Gámez Rodríguez; Ilya Sagaró Zambrano; Nayime Y Navas Napóles; Javier García Zacarías; Orlando R Serrano Barrera; María B Ramírez Bautista; Annelié Estupiñán Rodríguez; Leonardo A Guerra Rondón; Yaimeé Vázquez-Mojena; Yanetza González-Zaldivar; Luis E Almaguer Mederos; Alejandro Leyva-Mérida
Journal:  Cerebellum       Date:  2020-04       Impact factor: 3.847
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.